Clinical Presentation of Lung Cancer

Signs and Symptoms of Lung Cancer Introduction Lung cancer presents with a wide variety of signs and symptoms that depend on three main factors: the size and location of the primary tumor, whether it has spread to other organs, and whether the cancer produces abnormal hormones or triggers immune responses. Understanding these presentations is crucial because early detection often requires recognizing these symptoms, and later presentations often involve serious complications. Early Disease: The Silent Problem Early-stage lung cancer presents a diagnostic challenge because tumors in the lung often produce no symptoms. Unlike cancers that grow on the skin or cause obstruction quickly, small lung tumors may grow for months or years without causing any noticeable effects. This is why many lung cancers are discovered incidentally on imaging done for other reasons, or only detected through screening programs using low-dose CT scans. The fundamental problem: lung tissue itself has relatively few pain receptors, so a small tumor can grow substantially without triggering symptoms. Respiratory Symptoms: Direct Effects on the Lungs When lung cancer does cause symptoms, respiratory manifestations are among the earliest and most common presentations. New or worsening cough is the classic sign of lung cancer. A persistent cough lasting more than 2-3 weeks, especially in someone with a smoking history or risk factors, warrants investigation. This occurs because the tumor irritates the airway lining. Hemoptysis (coughing up blood) occurs in approximately 25% of patients. This ranges from small streaks of blood in sputum to large amounts of bleeding, and occurs when the tumor erodes into blood vessels in the lung. Hemoptysis is particularly concerning because it's alarming to patients and suggests the tumor is large enough to have invaded the airway. Shortness of breath affects about 50% of patients. This can result from several mechanisms: the tumor itself taking up space, fluid accumulation around the lungs (pleural effusion), or the tumor blocking airways and preventing proper gas exchange. Chest pain occurs in 25-50% of patients and typically has a dull quality. This happens when the tumor invades the pleura (the membrane lining the lungs) or chest wall, structures that are pain-sensitive. Systemic Symptoms: General Cancer Effects Lung cancer, like most malignancies, produces general "constitutional" symptoms reflecting the body's response to the malignancy: Weight loss and loss of appetite result from cancer's metabolic effects and production of inflammatory substances General weakness and fatigue accompany the body's fight against the cancer Fever and night sweats result from inflammatory cytokines released by the tumor and the immune system's response These systemic symptoms develop gradually and are often attributed to other causes, which can delay diagnosis. Location-Specific Symptoms: Where the Tumor Grows Matters The location of the tumor dramatically affects which symptoms develop, since cancer causes problems by: Obstructing (blocking) structures Compressing (squeezing) nearby tissues Invading (growing into) vital structures Tracheal obstruction: Tumors growing into or against the trachea (windpipe) cause progressive difficulty breathing and stridor (a high-pitched breathing sound). Esophageal compression: The esophagus lies adjacent to the trachea. Tumors pressing on it cause dysphagia (difficulty swallowing), beginning with solid foods and progressing to liquids as the obstruction worsens. Laryngeal nerve involvement: The recurrent laryngeal nerve runs from the brain through the chest to the larynx (voice box). Tumors in the left-sided lung can compress this nerve and cause hoarseness or voice changes. This occurs because the nerve cannot function when compressed, preventing vocal cord movement. Horner's syndrome: Tumors near the sympathetic nerve chain can disrupt it, causing this distinctive syndrome characterized by a drooping eyelid (ptosis), constricted pupil (miosis), and decreased sweating on one side of the face. This is a specific neurological sign that points toward lung cancer in the appropriate clinical context. Pancoast tumors: These are tumors growing at the lung apex (top). They cause a characteristic syndrome: Severe shoulder pain that radiates down the arm, particularly along the small-finger side (ulnar distribution) Destruction of upper ribs, visible on imaging Possible Horner's syndrome (if the sympathetic chain is involved) This syndrome is named for the radiologist who first described it and represents a specific anatomical presentation that physicians must recognize. Supraclavicular lymphadenopathy: Swollen lymph nodes above the collarbone indicate that cancer has spread from the lung to regional lymph nodes, suggesting more advanced disease. Superior vena cava syndrome (SVCS): The superior vena cava is the major vein bringing blood from the upper body back to the heart. When a tumor compresses or invades it, venous drainage becomes impaired, causing: Swelling of the face, neck, and upper extremities Distended neck veins Shortness of breath In severe cases, cerebral edema (brain swelling) SVCS is a medical emergency requiring prompt treatment. Cardiac involvement: Direct invasion of the heart or pericardium (heart sac) can cause: Pericardial effusion (fluid around the heart), which may tamponade the heart and impair its function Arrhythmias from irritation of heart tissue Heart failure if large portions of the myocardium are invaded Metastatic Symptoms: Cancer Spread to Distant Organs When lung cancer spreads beyond the lungs, it causes symptoms based on which organs are affected. Brain metastases are common, especially from small cell lung cancer. Symptoms include: Headaches (often the first symptom) Nausea and vomiting from increased intracranial pressure Seizures (occur in about 10-15% of patients with brain metastases) Focal neurological deficits (weakness, vision problems, speech difficulties) depending on tumor location Bone metastases cause: Bone pain at the site of involvement Increased fracture risk, sometimes leading to pathological fractures from minor trauma Spinal cord compression if metastases involve the spine, which is a medical emergency causing progressive paralysis Liver metastases produce: Right upper quadrant abdominal pain Hepatomegaly (enlarged liver) on examination Fever and weight loss Later: jaundice and signs of liver failure if extensive Bone marrow infiltration (less common) causes leukoerythroblastosis, an unusual blood picture showing immature white and red blood cells in the peripheral blood smear—an ominous sign of extensive bone marrow involvement. Paraneoplastic Syndromes: Cancer's Systemic Effects Beyond Metastases Paraneoplastic syndromes are clinical effects caused by the cancer itself (often through hormone or antibody production) rather than by tumor invasion or metastasis. These are particularly important because they can be the first sign of cancer and may mimic other conditions. Hypercalcemia is the most common paraneoplastic endocrine syndrome in lung cancer. It occurs through two mechanisms: Tumors producing PTHrP (parathyroid hormone-related protein) Tumors producing calcitriol (active vitamin D) Elevated calcium causes: Nausea and vomiting Abdominal pain and constipation ("stone, bone, and psychiatric overtone" is the classic mnemonic, with constipation being the "stone") Polyuria and polydipsia (excessive urination and thirst) Neuropsychiatric effects: confusion, depression, even psychosis The severity can be life-threatening, requiring urgent treatment. Hypokalemia (low potassium) results from ectopic ACTH production by small cell carcinomas. ACTH causes cortisol overproduction, which increases urinary potassium loss. This can cause severe muscle weakness and cardiac arrhythmias. Hyponatremia (low sodium) occurs through either: Syndrome of inappropriate ADH (SIADH): the cancer secretes antidiuretic hormone, causing water retention Atrial natriuretic peptide production: some tumors produce this hormone Hyponatremia causes confusion, seizures, and in severe cases, coma. Nail clubbing and hypertrophic pulmonary osteoarthropathy (HPO): Nail clubbing (enlargement of the nail bed and loss of the normal angle at the nail base) occurs in approximately one-third of lung cancer patients HPO is a more severe paraneoplastic syndrome occurring in up to 10% of patients, featuring nail clubbing plus joint pain (particularly in wrists, ankles, and knees) and skin thickening over the lower extremities The mechanism remains poorly understood but may involve platelet aggregates and growth factor release Autoimmune paraneoplastic disorders occur when the body develops antibodies against cancer antigens that cross-react with nervous system proteins: Lambert-Eaton myasthenic syndrome (LEMS): produces progressive muscle weakness, particularly affecting the legs, with characteristic improvement after exercise (opposite of myasthenia gravis) Sensory neuropathies: cause progressive burning pain and numbness in the extremities Inflammatory myopathies: cause muscle weakness Encephalitis and cerebellar degeneration: cause confusion, memory loss, ataxia, and loss of coordination These autoimmune syndromes can appear before the cancer is detected, making paraneoplastic syndrome recognition important for diagnosis. Paraneoplastic coagulation disorders occur in up to 1 in 12 patients and include: Migratory thrombophlebitis (recurrent blood clots in different veins) Intracardiac thrombi (clots in the heart chambers) Disseminated intravascular coagulation (DIC): uncontrolled clotting followed by depletion of clotting factors, leading to severe bleeding These disorders significantly increase mortality risk. Key Summary Understanding lung cancer's presentation requires recognizing that symptoms depend critically on tumor location (what it compresses or invades), tumor extent (local vs. metastatic), and tumor biology (whether it produces abnormal hormones). Early recognition of respiratory symptoms, location-specific syndromes, and paraneoplastic phenomena can lead to earlier diagnosis and better outcomes.